A
Aligos Therapeutics D
D
ALGS
22.480
USD
1.15
(5.39%)
Market Open
Volume
4,845
EPS
-4
Div Yield
-
P/E
-3
Market Cap
80,655,812
Novo Nordisk Surges in Profit and Sales
6 months ago
Stocks news More
Title: Aligos Therapeutics Inc
Sector: Healthcare
Industry: Biotechnology
Aligos Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.